Department of Urology, School of Medicine, University of California San Francisco, San Francisco, California.
Department of Surgery, San Francisco Veterans Affairs Medical Center, San Francisco, California.
J Urol. 2022 Apr;207(4):885-892. doi: 10.1097/JU.0000000000002352. Epub 2021 Dec 2.
When seeking treatment for male stress urinary incontinence (mSUI), patients are faced with weighing complex risks and benefits in making treatment decisions within their individual context. We sought to quantify the frequency of decisional regret among this population and to determine factors associated with regret.
A cohort of 130 males aged ≥65 years seen for initial mSUI consultation at the University of California, San Francisco Medical Center and the San Francisco Veterans Affairs Medical Center between June 2015 and March 2020 was developed. Using retrospective chart review and telephone interviews, we ascertained decisional regret as well as other patient-, disease- and treatment-related characteristics. Decisional regret was analyzed by treatment type and patient-, disease- and treatment-related factors. Multivariable logistic regression models were built to examine the factors most associated with decisional regret.
Among the entire cohort, 22% reported moderate to severe decisional regret. Regret was highest among those electing conservative management, with 34.7% having decisional regret (vs with surgery: 8.3% sling, 8.2% sphincter; p <0.001). In multivariable analysis, depression, lower rating of shared decision making and higher current incontinence scores were significantly associated with decisional regret.
Recognition of depression, improved efforts at shared decision making and more individualized treatment counseling have the potential to improve patient satisfaction with treatment choice. In addition, given high levels of regret among those electing conservative treatment, we may be underutilizing mSUI surgery in this population.
男性压力性尿失禁(mSUI)患者在治疗时需要权衡个体情况下治疗决策的复杂风险和获益。本研究旨在量化该人群中决策后悔的发生频率,并确定与后悔相关的因素。
我们建立了一个队列,纳入了 2015 年 6 月至 2020 年 3 月期间在加利福尼亚大学旧金山医疗中心和旧金山退伍军人事务医疗中心因初始 mSUI 就诊的 130 名年龄≥65 岁的男性。通过回顾病历和电话访谈,我们确定了决策后悔以及其他与患者、疾病和治疗相关的特征。我们根据治疗类型以及患者、疾病和治疗相关因素分析了决策后悔。采用多变量逻辑回归模型,探讨与决策后悔最相关的因素。
在整个队列中,22%的患者报告存在中重度决策后悔。选择保守治疗的患者中,决策后悔发生率最高(34.7%,而手术组为 8.3%吊带手术,8.2%括约肌手术;p<0.001)。多变量分析显示,抑郁、共享决策评分较低和当前尿失禁评分较高与决策后悔显著相关。
识别抑郁、改善共享决策以及更个体化的治疗咨询有可能提高患者对治疗选择的满意度。此外,鉴于选择保守治疗的患者中存在较高的后悔率,我们可能在该人群中过度使用 mSUI 手术。